Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Syndevrx, Inc.

Clinical trials sponsored by Syndevrx, Inc., explained in plain language.

Trials to join now! 1

New Triple-Drug combo aims to tame breast cancer and its side effects

Disease control Recruiting now

This study tests a new drug, evexomostat, added to two standard treatments for a common type of advanced breast cancer (HR+, HER2-). The goal is to see if the triple combination is safe and can reduce severe blood sugar spikes, a common side effect of current therapies. About 52 …

Phase: PHASE1, PHASE2 • Sponsor: SynDevRx, Inc. • Aim: Disease control

Last updated May 26, 2026 05:33 UTC